One Stop Shop for All Your Market Research Reports

Global Neurological Disorder Drugs Market 2018 Industry Research Report

This report studies the global market size of Neurological Disorder Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neurological Disorder Drugs in these regions. This research report categorizes the global Neurological Disorder Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson?s Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing rising focus on research and development programs that will help in producing affordable and effective drugs. The countries are collectively spending on developing neurological disorder drugs thus, improving the revenue of the market during the forecast period. Staggering increase in brain altering disorders such as Alzheimer?s, epilepsy, Parkinson?s, cerebrovascular, and sclerosis are promoting the pharmaceutical firms to tap into the significantly growing neurological disorder drugs market. This will potentially supplement the market growth in the coming years. Rise of several innovative drugs to manage these diseases will swell up the investments in the market. Increasing number of clinical trials are another reason boosting the market. Rise in geriatric population along with patients with strokes, migraines, and headaches leading to cerebrovascular diseases are likely to augment the growth of the market. In 2017, the global Neurological Disorder Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Neurological Disorder Drugs market based on company, product type, application and key regions. The various contributors involved in the value chain of Neurological Disorder Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Neurological Disorder Drugs include Novartis AG GlaxoSmithKline plc Merck & Co. Bayer AG AstraZeneca Boehringer Ingelheim GmbH Teva Pharmaceutical Market Size Split by Type Antipsychotic Hypnotic & Sedative Analgesics Anticoagulants Others Market Size Split by Application Hospital Clinic Market size split by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Neurological Disorder Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. To understand the structure of Neurological Disorder Drugs market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Neurological Disorder Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Neurological Disorder Drugs with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Neurological Disorder Drugs submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Neurological Disorder Drugs are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neurological Disorder Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Neurological Disorder Drugs Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Neurological Disorder Drugs Market Size Growth Rate by Type 1.4.2 Antipsychotic 1.4.3 Hypnotic & Sedative 1.4.4 Analgesics 1.4.5 Anticoagulants 1.4.6 Others
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Corporate User US $7800
About this Report
Report ID 253534
Category
  • Pharmaceuticals and Healthcare
Published on 20-Sep
Number of Pages 112
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(38)